查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1542860

全球生物醫學嵌入式系統市場 - 2024-2031

Global Biomedical Embedded Systems Market - 2024-2031
出版日期: | 出版商: DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

全球生物醫學嵌入式系統市場在2023年達到1.7025億美元，預計到2031年將達到3.4874億美元，在2024-2031年預測期間複合年成長率為9.7%。

生物醫學嵌入式系統是整合硬體和軟體組件的電子系統，用於監測、診斷和管理人類健康的各個方面。這些系統由微控制器、感測器和其他組件組成，共同收集和處理生理資料。它們嵌入到穿戴式裝置、植入裝置和診斷工具等醫療設備中，從而實現即時資訊傳遞、提高準確性並改善患者治療結果。

市場動態：

驅動程式和限制

慢性病盛行率上升

近年來，隨著慢性病的興起，對診斷、預後和患者管理等遠距醫療應用的需求日益成長。嵌入式系統技術已在生物醫學技術中佔有重要地位。特別是開發工具，以在大流行等過程中發生流行性傳染病時提高醫護人員的安全。

例如，根據美國疾病管制與預防中心 (CDC) 統計，到 2024 年，美國將有 1.29 億人患有至少一種主要慢性疾病，包括心臟病、癌症、糖尿病、肥胖和高血壓。美國十大死亡原因中有五個與可預防和可治療的慢性病有關。

在過去的二十年裡，盛行率穩定上升，這種趨勢預計將持續下去。越來越多的美國人患有多種慢性病，其中 42% 的人患有兩種或兩種以上，12% 的人患有至少五種慢性病。慢性病也對美國醫療保健系統產生重大影響，佔年度 4.1 兆美元支出的 90%。

嵌入式系統容易遭受安全漏洞和網路威脅

阻礙產業成長的關鍵因素之一是嵌入式設備的安全性。軍隊、銀行、資料中心和醫療機構都依賴嵌入式設備（包括記憶體）來保留潛在的關鍵資訊。因此，必須不惜一切代價避免網路安全風險和違規行為。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 慢性病盛行率上升
      • 設備的進步
    • 限制
      • 嵌入式系統容易遭受安全漏洞和網路威脅
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 專利分析
  • 大環境分析
  • SWOT分析
  • DMI 意見

第 6 章：按組件

  • 軟體
  • 硬體

第 7 章：按申請

  • 穿戴式裝置
  • 植入式裝置
  • 診斷設備
  • 治療設備

第 8 章：最終用戶

  • 醫院
  • 診所
  • 家庭護理設置
  • 其他

第 9 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 11 章：公司簡介

  • Medtronic plc
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Philips Healthcare
  • Siemens Healthineers
  • General Electric (GE) Healthcare
  • Roche Diagnostics
  • Johnson & Johnson
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Texas Instruments
  • Analog Devices

第 12 章：附錄

簡介目錄
Product Code: MD8591

Overview

Global Biomedical Embedded Systems Market reached US$ 170.25 million in 2023 and is expected to reach US$ 348.74 million by 2031, growing at a CAGR of 9.7% during the forecast period 2024-2031.

Biomedical embedded systems are electronic systems that integrate hardware and software components to monitor, diagnose, and manage various aspects of human health. These systems, consisting of microcontrollers, sensors, and other components, work together to collect and process physiological data. They are embedded in medical devices like wearables, implantables, and diagnostic tools, enabling real-time information delivery, enhanced accuracy, and improved patient outcomes.

Market Dynamics: Drivers & Restraints

Rise in the prevalence of chronic diseases

In recent years, with the rise of chronic diseases, there has been a growing need for telemedicine applications such as diagnosis, prognosis, and patient management. Embedded system technologies have occupied an important area in biomedical technology. Especially, to develop tools for the purposes of increasing the safety of healthcare workers in the event of epidemic infectious diseases in processes such as pandemics.

For instance, according to the CDC, in 2024, the US has 129 million people with at least one major chronic disease, including heart disease, cancer, diabetes, obesity, and hypertension. Five of the top 10 leading causes of death in the US are associated with preventable and treatable chronic diseases.

Over the past two decades, prevalence has steadily increased, and this trend is expected to continue. An increasing proportion of Americans are dealing with multiple chronic conditions, with 42% having two or more and 12% having at least five. Chronic diseases also significantly impact the US healthcare system, accounting for 90% of annual $4.1 trillion expenditure.

Vulnerability of embedded systems to security breaches and cyber threats

One of the key factors slowing industry growth is the security of embedded devices. Military forces, banks, data centers, and healthcare facilities all rely on embedded devices, including memory, to retain potentially critical information. As a result, cybersecurity risks and breaches must be avoided at all costs.

Segment Analysis

The global biomedical embedded systems market is segmented based on component, application, end-user, and region.

The software from the component segment accounted for approximately 54.1% of the biomedical embedded systems market share

Software is a vital component in the biomedical embedded systems market, enhancing the functionality and efficiency of medical devices. It integrates complex algorithms and data processing capabilities, managing and interpreting medical data, controlling hardware components, and ensuring real-time responsiveness.

Software also aids in the development of advanced diagnostics, monitoring, and therapeutic solutions, while supporting regulatory compliance and security measures. As technology advances, software continues to drive innovation and improve the accuracy and reliability of biomedical embedded systems.

For instance, in November 2023, SolidWorld Group S.p.A. upgraded its Electrospider, the first three-dimensional bioprinter capable of replicating human cell tissue, with the incorporation of advanced proprietary Artificial Intelligence. This technological advancement represents a significant step in the future of biomedical engineering.

Geographical Analysis

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period due to advancements in healthcare technology and increasing demand for advanced medical devices. The region benefits from a strong healthcare infrastructure, high investment in research and development, and a robust presence of leading medical technology companies. Innovations like wearable health monitors, advanced diagnostic tools, and remote patient management systems are crucial for personalized healthcare and improving patient outcomes. North American regulations promote high-quality, safe, and reliable medical devices.

Market Segmentation

By Component

  • Software
  • Hardware

By Application

  • Wearable Devices
  • Implantable Devices
  • Diagnostic Devices
  • Therapeutic Devices

By End User

  • Hospitals
  • Clinics
  • Home care settings
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

The major global players in the market include Medtronic plc, Philips Healthcare, Siemens Healthineers, General Electric (GE) Healthcare, Roche Diagnostics, Johnson & Johnson, Abbott Laboratories, Boston Scientific Corporation, Texas Instruments, Analog Devices among others.

Key Developments

  • In January 2022, Onera Health announced the introduction of its first Onera Biomedical-Lab-on-Chip. The biomedical sensor system-on-chip acquires and processes multiple biosignals and is designed for a broad range of wearable health applications and devices, offering many solutions and opportunities for innovation in the medical, wellness, and fitness space.

Why Purchase the Report?

  • To visualize the global biomedical embedded systems market segmentation based on component, application, end-user, and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of the biomedical embedded systems market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global biomedical embedded systems market report would provide approximately 64 tables, 61 figures and 186 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Component
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the prevalence of chronic diseases
      • 4.1.1.2. Advancements in the devices
    • 4.1.2. Restraints
      • 4.1.2.1. Vulnerability of embedded systems to security breaches and cyber threats
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Patent Analysis
  • 5.6. PESTLE Analysis
  • 5.7. SWOT Analysis
  • 5.8. DMI Opinion

6. By Component

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 6.1.2. Market Attractiveness Index, By Component
  • 6.2. Software*
    • 6.2.1. Introduction
  • 6.3. Hardware

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 7.2. Market Attractiveness Index, By Application
  • 7.3. Wearable Devices*
    • 7.3.1. Introduction
    • 7.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.4. Implantable Devices
  • 7.5. Diagnostic Devices
  • 7.6. Therapeutic Devices

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Clinics
  • 8.4. Home care settings
  • 8.5. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. UK
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Medtronic plc*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Philips Healthcare
  • 11.3. Siemens Healthineers
  • 11.4. General Electric (GE) Healthcare
  • 11.5. Roche Diagnostics
  • 11.6. Johnson & Johnson
  • 11.7. Abbott Laboratories
  • 11.8. Boston Scientific Corporation
  • 11.9. Texas Instruments
  • 11.10. Analog Devices

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us